Literature DB >> 11825113

The use of TaqMan PCR assay for detection of Bordetella pertussis infection from clinical specimens.

Edward L Chan1, Nick Antonishyn, Ryan McDonald, Tara Maksymiw, Peter Pieroni, Evelyn Nagle, Greg B Horsman.   

Abstract

OBJECTIVE: The routine clinical laboratory detection of Bordetella pertussis is through culture, which can require 5 to 7 days for the bacteria to grow. Using a polymerase chain reaction (PCR) assay can shorten this detection time while increasing the sensitivity of detection with similar specificity. This study compared culture with TaqMan PCR for detection of B pertussis in clinical specimens and the turnaround time for each assay during the pertussis season.
MATERIALS AND METHODS: Nasopharyngeal swabs in Regan-Lowe transport media were collected from 1556 persons who had symptoms of whooping cough or who had had contact with infected persons; the swabs were submitted for B pertussis detection during the pertussis season. A single nasopharyngeal swab from each patient was submitted for both culture and TaqMan PCR detection. Upon receipt of the specimens, the swabs were inoculated onto Regan-Lowe agar for culture and incubated for up to 7 days. The same swab was processed for PCR detection using TaqMan PCR assay. A second nested PCR was used on positive specimens for resolution purposes. The TaqMan PCR assay was performed 3 to 5 days a week, whereas the culture was performed 6 days a week. All specimens were processed on the same day or earliest possible working day for TaqMan or culture, and specimens queued for resolution by nested PCR were batched.
RESULTS: There were a total of 275 PCR positives and 28 culture positives. After resolution with the second nested PCR, the sensitivity, specificity, positive predictive value, and negative predictive value were 100%, 97.4%, 87.6%, and 100% for TaqMan PCR and 11.6%, 100%, 100%, and 85.7% for culture. The average turnaround time for positive culture was 5.1 days, and the average turnaround time for PCR was 2.3 days.
CONCLUSION: The TaqMan PCR assay has superior sensitivity and shorter turnaround time over culture because it can be finished within one working day. Furthermore, the same swab can be used for culture of the bacteria for antibiotic susceptibility testing. The early detection of pertussis using TaqMan PCR assay allows early intervention on the spread of the disease and the ability to culture the bacteria from the same swab, thereby eliminating the need for a second swab and allowing for detection of antibiotic resistance.

Entities:  

Mesh:

Year:  2002        PMID: 11825113     DOI: 10.5858/2002-126-0173-TUOTPA

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  10 in total

1.  External quality assessment for molecular detection of Bordetella pertussis in European laboratories.

Authors:  G Muyldermans; O Soetens; M Antoine; S Bruisten; B Vincart; F Doucet-Populaire; N K Fry; P Olcén; J M Scheftel; J M Senterre; A van der Zee; M Riffelmann; D Piérard; S Lauwers
Journal:  J Clin Microbiol       Date:  2005-01       Impact factor: 5.948

Review 2.  Real-time PCR in clinical microbiology: applications for routine laboratory testing.

Authors:  M J Espy; J R Uhl; L M Sloan; S P Buckwalter; M F Jones; E A Vetter; J D C Yao; N L Wengenack; J E Rosenblatt; F R Cockerill; T F Smith
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

3.  2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings.

Authors:  Jane D Siegel; Emily Rhinehart; Marguerite Jackson; Linda Chiarello
Journal:  Am J Infect Control       Date:  2007-12       Impact factor: 2.918

4.  The laboratory diagnosis of Bordetella pertussis infection: a comparison of semi-nested PCR and real-time PCR with culture.

Authors:  B Abu Raya; E Bamberger; R Gershtein; M Peterman; I Srugo
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-07-09       Impact factor: 3.267

Review 5.  Laboratory Diagnosis of Pertussis.

Authors:  Anneke van der Zee; Joop F P Schellekens; Frits R Mooi
Journal:  Clin Microbiol Rev       Date:  2015-10       Impact factor: 26.132

6.  Progress in the Diagnosis, Prevention, and Treatment of Pertussis.

Authors:  Flor M. Munoz; Wendy A. Keitel
Journal:  Curr Infect Dis Rep       Date:  2003-06       Impact factor: 3.725

7.  Using a bayesian latent class model to evaluate the utility of investigating persons with negative polymerase chain reaction results for pertussis.

Authors:  Gillian A M Tarr; Jens C Eickhoff; Ruth Koepke; Daniel J Hopfensperger; Jeffrey P Davis; James H Conway
Journal:  Am J Epidemiol       Date:  2013-06-04       Impact factor: 4.897

8.  Swabbing for respiratory viral infections in older patients: a comparison of rayon and nylon flocked swabs.

Authors:  S S Hernes; H Quarsten; E Hagen; A L Lyngroth; A H Pripp; B Bjorvatn; P S Bakke
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-09-18       Impact factor: 3.267

9.  Comparing the Yield of Nasopharyngeal Swabs, Nasal Aspirates, and Induced Sputum for Detection of Bordetella pertussis in Hospitalized Infants.

Authors:  Marta C Nunes; Nasiha Soofie; Sarah Downs; Naume Tebeila; Azwi Mudau; Linda de Gouveia; Shabir A Madhi
Journal:  Clin Infect Dis       Date:  2016-12-01       Impact factor: 9.079

10.  Pertussis may be the cause of prolonged cough in adolescents and adults in the interepidemic period.

Authors:  Analíria Moraes Pimentel; Paulo Neves Baptista; Ricardo Arraes de Alencar Ximenes; Laura Cunha Rodrigues; Vera Magalhães; Andrea Rosane Sousa Silva; Nadjla Ferreira Souza; Deize Gomes Cavalcanti de Matos; Ana Kelly Lins Pessoa
Journal:  Braz J Infect Dis       Date:  2014-10-14       Impact factor: 3.257

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.